Streetbeat News

Products Services

PCVX

Vaxcyte, Inc. (NASDAQ:PCVX) and Lonza have expanded their collaboration with a new commercial manufacturing agreement. This agreement supports the potential global commercialization of Vaxcyte's pneumococcal conjugate vaccine (PCV) candidates, VAX-24 and VAX-31. Lonza will provide a custom-built manufacturing suite at its Visp site to manufacture key components for Vaxcyte's PCV franchise. The suite is expected to meet the potential long-term market demand for both adult and pediatric populations globally. Equipment installation is expected to begin in 2024, creating up to 300 new jobs.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:33 pm

IMAX

IMAX Corporation has announced a $13 million debut for 'TAYLOR SWIFT: THE ERAS TOUR'.

Portfolio Pulse from Bill Haddad

October 16, 2023 | 12:32 pm

BA

KTOS

Kratos Defense & Security Solutions (KTOS) and Boeing (BA) have signed a Memorandum of Understanding for the TDI-J85 turbine engine to provide propulsion for the Powered Joint Direct Attack Munition (JDAM). The TDI-J85 engine, developed by Kratos' business unit Technical Directions, Inc. (TDI), will be used in Boeing's Powered JDAM, a low-cost, high-range weapon system. The TDI-J85 engine is capable of producing 200-lbf of net thrust at Sea-Level Static conditions and is compatible with commercial and/or military kerosene-grade turbine fuels.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:32 pm

MDAI

Spectral AI, Inc. (NASDAQ:MDAI) has announced the addition of seven clinical sites to support the development of its diabetic foot ulcer (DFU) application for the DeepView® Wound Imaging System. The technology combines multi-spectral imaging and AI to provide immediate healing assessments of DFUs. The data collected from these sites will be used to develop the DFU healing prediction algorithm and support applications for FDA, UKCA, and CE mark approval for DeepView®'s DFU indication.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:31 pm

TOVX

Theriva Biologics (NYSE:TOVX) has announced the presentation of Phase 1 data from a study evaluating VCN-01 in combination with durvalumab for patients with recurrent/metastatic squamous cell carcinoma of the head and neck. The study, conducted in collaboration with the Institut Catala d'Oncologia, showed enhanced patient survival, correlating with VCN-01 induced upregulation of PD(L)-1. The data will be presented at the European Society for Medical Oncology Congress in October 2023.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:31 pm

RUM

Rumble, a video platform, will be the exclusive livestream provider for the third GOP debate of the 2024 Presidential Primaries. No specific financial details were disclosed.

Portfolio Pulse from Bill Haddad

October 16, 2023 | 12:30 pm

SCYX

SCYNEXIS, Inc. (NASDAQ:SCYX) announced the presentation of preclinical data on its second generation antifungal compound, SCY-247, at the 11th Congress on Trends in Medical Mycology. SCY-247 has demonstrated broad-spectrum antifungal activity and SCYNEXIS anticipates that the FDA may grant it Qualified Infectious Disease Product and Fast Track designations. Clinical studies are planned to begin in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:27 pm

CRBP

Corbus Pharmaceuticals has presented pre-clinical characterization of Nectin-4 ADC CRB-701, demonstrating a differentiated nonclinical profile relative to enfortumab vedotin. Early dose escalation clinical data supports these differentiating features. The company is on schedule to initiate its US study in Q1-2024.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:26 pm

FCEL

FuelCell Energy, Inc. (NASDAQ:FCEL) and Oando Clean Energy Limited (OCEL) have signed a memorandum of understanding (MOU) to develop a 5 to 15-Megawatt power plant in Africa. The agreement includes the potential use of FuelCell Energy's fuel cell, electrolyzer, and carbon capture technologies. This collaboration is part of OCEL's initiative to strengthen electricity access in African markets via low-carbon renewable energy sources, starting in Nigeria. The Nigerian government aims to increase the share of renewable electricity to 30% by 2030 and achieve net zero emissions by 2060.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:26 pm

INCY

Incyte has announced that new data from its oncology portfolio will be presented at the ESMO Congress 2023.

Portfolio Pulse from Benzinga Newsdesk

October 16, 2023 | 12:25 pm